Dec 2024
Post-IPO Debt - Core Scientific
$550M
Aug 2024
Post-IPO Debt - Core Scientific
$400M
Jul 2024
Post-IPO Equity - Core Scientific
$260M
Nov 2023
Post-IPO Equity - Core Scientific
$55M
Sept 2023
Post-IPO Equity - Core Scientific
$54M
Jan 2023
Post-IPO Debt - Core Scientific
$70M
Oct 2021
Convertible Note - Core Scientific
Undisclosed
Jul 2021
Corporate Round - Core Scientific
$54M
May 2020
Debt Financing - Core Scientific
$21M
Feb 2020
Series A - Core Scientific
$44M
Dec 2018
Funding Round - Core Scientific
$50M